冠脉内推注替罗非班的患者，与那些静脉推注替罗非班的相比，其LVEF、L

Compared with those patients who received intracoronary bolus tirofiban, their LVEF and LVEDD levels were increased, and their LVESD levels decreased significantly, indicating that high burden was found in STEMI patients with diabetes during PPCI. In patients with coronary thrombosis, intra-coronary injection of tirofiban can significantly improve the heart function of patients.

Compared with those who intravenously inferred teropic class, the level of LVEF and LVEDD can be raised, and the decrease of LVESD level is more significant, indicating that in patients with STEMI with diabetes PPCI found that high-load coronary blood clot patients through intra-coronary intestinal infusion of terofeban, can make the patient's heart function improve significantly.

Compared with intravenous injection of tirofiban, the levels of LVEF and LVEDd in patients with intracoronary injection of tirofiban can be increased, while the level of LVESD is decreased significantly, which indicates that in patients with STEMI complicated with diabetes mellitus undergoing PPCI, intracoronary injection of tirofiban can significantly improve the cardiac function.<br>